Physician profile
Greg D Cohen
NPI 1235119736
$740.09
in general payments reported to CMS, 2019-2025
16 companies · $32.85 in 2025
The $32.85 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $17.79 · 2021: $201 · 2022: $132 · 2023: $181 · 2024: $65.75 · 2025: $32.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $280.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $174.91 | 2021-2023 | |
| Novo Nordisk INC | $136.59 | 2019-2021 | |
| Abbvie INC. | $85.13 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.46 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $39.35 | 2019 | |
| Amarin Pharma, INC. | $38.23 | 2021 | |
| Xeris Pharmaceuticals, INC. | $36.08 | 2022-2023 | Gvoke Hypopen |
| Otsuka America Pharmaceutical, INC. | $32.40 | 2023-2024 | Rexulti, Abilify Maintena |
| Lilly USA, LLC | $30.98 | 2024 | Mounjaro |
| Abbott Laboratories | $20.00 | 2024 | Freestyle Libre 2 |
| Allergan, INC. | $17.79 | 2020 | |
| Glaxosmithkline, LLC. | $16.90 | 2019 | |
| Pfizer INC. | $15.84 | 2023 | |
| Novartis Pharmaceuticals Corporation | $15.20 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.31 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.